SIT­U­A­TION

• Neo­Surg Tech­nolo­gies, Inc. (“The Com­pa­ny”) designs and mar­kets tro­cars – sur­gi­cal devices that are used in all laparo­scop­ic surgery procedures
• Their patent-pro­tect­ed prod­ucts includ­ed a hybrid tro­car sys­tem that has advan­tages of both reusable and dis­pos­able tro­cars, and a pro­pri­etary seal that fits every reusable tro­car avail­able in the market
• Laparo­scop­ic surgery was among the fastest grow­ing seg­ments of the health­care indus­try and became the dom­i­nant method for most sur­gi­cal pro­ce­dures in the abdom­i­nal cav­i­ty, and was the pre­ferred sur­gi­cal tech­nique among doc­tors, patients and insur­ance companies
• The num­ber of laparoscopy pro­ce­dures was pro­ject­ed to increase two to four-fold over the next five years, dri­ven by the appli­ca­tion of new tech­nolo­gies and an aging population
• Chi­ron was engaged as finan­cial advi­sor in a $5 MM cap­i­tal raise & facil­i­tat­ed the Company’s growth

OUT­COME

• Chi­ron mar­ket­ed the cap­i­tal raise to over 500 ven­ture, pri­vate equi­ty, fam­i­ly office and strate­gic platforms

• Chi­ron suc­cess­ful­ly placed the cap­i­tal with John­son & Johnson